Stem cell transplant from a partially matched unrelated donor
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial tests a transplant using stem cells from an unrelated donor who is not a perfect match for your tissue type. It may be an option for people with blood cancers who can't find a fully matched related donor and need a transplant quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old
- You have a blood cancer (like leukemia or lymphoma) that needs a stem cell transplant
- A matched sibling or other close relative is not available for donation
- You do not have a fully matched (9 out of 10 or better) unrelated donor available, or your condition is urgent
- You have a willing donor who is a partial match (less than 9 out of 10 in tissue type)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a stem cell transplant from a family donor whose tissue type is only partly matched, for adults with blood cancers who don't have a fully matched sibling or other closely matched donor. The goal is to make transplant possible for more patients.
This trial tests a special type of stem cell transplant for people who don't have a perfectly matched sibling donor. It uses stem cells from a half-matched family member or a closely matched unrelated donor to treat cancers or other serious disorders.
This trial tests a stem cell transplant using milder chemotherapy (treosulfan and fludarabine) followed by a drug called cyclophosphamide to prevent graft-versus-host disease. It aims to make transplant safer for people with blood diseases who cannot handle standard high-dose chemotherapy.
This trial studies transplanting healthy blood-forming cells from an umbilical cord blood donor who is not related to you. It may help people with certain blood cancers, immune disorders, or other serious diseases when a standard transplant plan is needed.
This trial tests a way to treat certain blood cancers using a stem cell transplant from a partially matched (haploidentical) donor. It aims to make the transplant safer and reduce the chance of the immune reaction that can follow transplant, using post-transplant cyclophosphamide and bortezomib.
This Phase 2 study tests a specific chemotherapy combination (treosulfan, fludarabine, and thiotepa) before an unrelated or matched donor stem cell transplant. It may help people with certain non-cancer blood and immune disorders by trying to reset the immune system using donor stem cells.
Hear when a new Hematologic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.